Recent studies on the regulation of social behaviours by neuropeptides indicate that it is the distribution of peptide receptor expression in particular brain areas that determines the specificity of peptide actions; and that, accordingly, peptides can evoke specific behaviours when administered centrally without temporal or spatial selectivity of administration. The release of neuropeptides at synaptic sites appears irrelevant, and in the brain, some peptides are released mainly from dendrites rather than from nerve endings. Dendritic peptide release can be long lasting, semi-independent of electrical activity, and allows the diffusion of peptides to distant targets. The peptide oxytocin regulates many behaviours; in particular, it inhibits food intake. Centrally, oxytocin is released in large amounts by the dendrites of hypothalamic magnocellular neurons. This mini-review considers the possible involvement of dendritically released oxytocin in the regulation of food intake by its actions on the ventromedial hypothalamus.
Introduction
In the brain, approx. 100 neuropeptides have been identified; many of these are expressed in distinct neuronal subpopulations in the hypothalamus, and several have profound effects on behaviours. Unlike 'classical' neurotransmitters, whose effectiveness depends on synaptic release that is spatially and temporally precise, neuropeptides can induce specific, long-lasting changes in behaviours when injected into the cerebrospinal fluid. This indicates that neither targeted delivery nor specific temporal patterning is essential. Peptides can be released in large amounts in the brain and can persist for several minutes because they are degraded only relatively slowly by peptidases [1] .
Oxytocin has been extensively studied for its peripheral role during lactation and parturition and also for its effects on sexual, feeding, maternal and social behaviours. Oxytocin is made in the SON (supraoptic nucleus) and PVN (paraventricular nucleus) of the hypothalamus, and is secreted into the blood by the nerve terminals of magnocellular neurons, which project to the posterior pituitary. In the brain, some oxytocin is released from parvocellular neurons in the PVN; these cells project to many brain areas, particularly the brainstem and spinal cord [2] . However, the dendrites of magnocellular neurons are the major suppliers of oxytocin in the brain [1] , and may be the main regulatory source of oxytocin-induced behaviours, in particular, oxytocin-induced inhibition of appetite and stimulation
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of sexual behaviour. One likely target of oxytocin for the regulation of these behaviours is the ventromedial nucleus of the hypothalamus [VMH (ventromedial hypothalamus)]. The VMH is an important appetite-inhibiting centre and a mediator of female sexual behaviours, and oxytocin receptor mRNA [3] and oxytocin-binding sites [4] are densely expressed there. Previous studies on the actions of oxytocin in the VMH have focused on its effects on female sexual behaviour, and the regulation of VMH oxytocin receptor by oestrogens [5, 6] ; there have been no studies so far of the actions of oxytocin in the VMH in the regulation of appetite.
Neuropeptides and behaviours
Studies by Insel and Young [7] on pair-bonding in voles offer one of the most eloquent illustrations of the hormone-like nature of the behavioural effects of peptides. They compared prairie voles, which bond monogamously after mating, and montane voles, a closely related but promiscuous species; in males, this difference is reflected as an increase in aggression towards other males. These studies showed that central injection of vasopressin facilitates aggression in male prairie voles but not in montane voles, and they attributed this to differences in the distribution of vasopressin V 1a receptor in the brain. The determining factor for both receptor distribution patterns and sociobehavioural traits lies in differences in the 5 -region of the vasopressin V 1a receptor gene [8] . CRF (corticotropin-releasing factor) also centrally modulates pair-bonding in prairie voles [9] , and as with the vasopressin V 1a receptor, the distribution of CRF receptors in the brain of monogamous vole species differs from that of non-monogamous species, and also between sexes [10] . These findings suggest that the actions of neuropeptides on behaviours depend less on the distribution of the peptide-containing fibres and more on the exact location of the receptors. This is consistent with the notion that, in the brain, peptides are not localized to synaptic sites of release but reach distant targets by diffusion.
Oxytocin and appetite
Centrally, oxytocin binds to high-affinity G-protein-coupled oxytocin receptors to modulate feeding, sexual and social behaviours [7, 11, 12] ; these effects reflect oxytocin released within the brain, as the blood-brain barrier prevents oxytocin released into the circulation from re-entering the brain. At several brain areas in which oxytocin exerts its behavioural effects, there is no consistent relationship between abundance of oxytocin receptors and density of innervation by oxytocin fibres. For example, in the olfactory bulb and amygdale [13] , sites important for the effects of oxytocin on social behaviours, there is a high density of oxytocin-binding sites but very few oxytocin fibres [2, 14] . The major source of oxytocin that acts at these areas is likely to be not the parvocellular system, but the magnocellular system [15] .
Oxytocin affects feeding behaviour, both peripherally and centrally, but its exact role is unclear. Verbalis and co-workers [11, [16] [17] [18] noted that, when there is a high plasma concentration of oxytocin, such as after dehydration, there is usually a loss of appetite. Systemically injected oxytocin does not affect feeding in rats [18] , but centrally injected oxytocin inhibits feeding even in fasted rats, and this can be blocked by an oxytocin antagonist [11] . The loss of appetite in dehydration is also attenuated by central injection of oxytocin antagonist [17] , and is reduced in oxytocin-deficient transgenic mice [19] . These effects have been associated with sodium appetite as, in hypovolemic rats, central injection of oxytocin abolished intake of saline without affecting water intake [16] .
Many parvocellular oxytocin neurons project to the NTS (nucleus tractus solitarii), where they modulate gastrointestinal motility; they innervate NTS neurons that are activated by systemic injections of CCK (cholecystokinin), a peptide released in the gut during feeding. CCK is thought to mediate in part meal-induced satiety, and oxytocin appears to potentiate the inhibitory action of CCK on meal size [20] . Parvocellular neurons also contribute to leptin-induced attenuation of feeding by relaying leptin signals from the arcuate nucleus to the NTS, increasing their sensitivity to satiety signals [21] .
Magnocellular oxytocin neurons are also active during feeding. Expression of Fos is increased in the SON during feeding in rats [22] and in ewes [23] , and both Fos expression and oxytocin secretion are activated by gastric distension or by systemic injections of CCK [24] (Fos is the protein product of the immediate-early gene c-fos, commonly used as a marker of neuronal activation). Several appetiteregulating factors affect magnocellular neurons. For example, the preproglucagon-derived peptide, GLP-1 (glucagon-like peptide-1), which inhibits food intake by its actions on GLP-1 receptors in the brain, induces c-fos expression in SON oxytocin cells [25] . It is not known whether feeding is accompanied by dendritic oxytocin release, but if so, a likely target for this release is the VMH.
The VMH and appetite regulation
The VMH has been recognized as a satiety centre since 1940, when it was reported that rats with lesions of the VMH display a 'voracious' appetite. The VMH can be subdivided into dorsomedial, central and ventrolateral regions based on the expression of transcription factors, receptors and neuropeptides [26] . These subpopulations are affected by many appetite-related signals, including leptin, ghrelin, orexin-A and CCK [27] . BDNF (brain-derived neurotrophic factor) and PACAP (pituitary adenylate cyclase-activating polypeptide) are expressed throughout the nucleus, whereas nitric oxide synthase, somatostatin and enkephalin are in the ventrolateral region only [26] . One interesting subpopulation of VMH neurons, which delineates the more dorsal and central regions, uniquely expresses the nuclear receptor SF1 (steroidogenic factor-1). Deletion of SF1 results in abnormal VMH development and obesity in mice [28] , and mutations of SF1 are linked to obesity and Type 2 diabetes in humans [29] . Leptin excites SF1 neurons in vitro, and the actions of leptin in the VMH help to resist diet-induced obesity [30] . Another population of VMH neurons is involved in glucose homoeostasis and contains neurons that respond to changes in extracellular glucose [31] ; these glucoreceptor neurons are also activated by leptin in vivo [32] .
The VMH projects to the anterior hypothalamus, the medial pre-optic area and the PVN and has major extrahypothalamic projections to the amygdala, the bed nucleus of the stria terminalis and the periaqueductal grey [26] . The dorsomedial region, which is specifically important for appetite, projects to the bed nucleus of the stria terminalis, the nucleus accumbens and the medial prefrontal cortex [26] . The medial VMH sends strong excitatory inputs to POMC (pro-opiomelanocortin) neurons in the arcuate nucleus; this connection is dynamically regulated by nutritional state, as it is weakened by fasting [33] .
The functional nature of VMH neurons, their electrical activity and how they are regulated in vivo are still largely unknown. There have been few studies of the electrical activity of VMH neurons in vivo since the classic papers that established its involvement in glucoresponsiveness [34, 35] . However, no in vivo studies investigated the responses of VMH neurons to appetite-regulating signals such as ghrelin and leptin and the interactions between the VMH and other areas involved in appetite regulation.
In many brain areas, biochemically distinct populations have distinct electrophysiological phenotypes; for instance, SON oxytocin neurons can be distinguished from neighbouring vasopressin neurons by their spontaneous discharge patterning [36] , and these differences reflect differences in intrinsic membrane properties. From our recordings of VMH cells in anaesthetized rats in vivo, several electrophysiologically distinct subpopulations of cells can be distinguished that differ both from each other and from other well-characterized neuronal populations. These subpopulations can be distinguished by distinctive, spontaneous firing patterns, as revealed by statistical analyses of interspike-interval patterning ( Figure 1A ). Our working hypothesis is that electrophysiologically distinct subpopulations are also biochemically and functionally distinct. This is being tested by comparing the responses of different subpopulations to appetiteregulating stimuli, including oxytocin ( Figure 1B) . Different subpopulations respond to intracerebroventricular oxytocin either by activation or by inhibition, or show no response.
The distinctive patterns of spike activity may reflect either distinct features of intrinsic membrane properties or their integration into particular neuronal 'mini networks'. Patch-clamp electrophysiology in vivo is a powerful way to determine whether subpopulations of neurons differ because of differences in their intrinsic properties, or because of different connections, or both. However, patch-clamp techniques have been used in vitro in most brain areas, but in vivo, only in the cortex and the spinal cord [37] [38] [39] . In preliminary experiments, we have recorded from VMH cells in both cell-attached and whole-cell configurations, allowing us to observe channel activity, firing activity and synaptic activity in several VMH cells ( Figure 1C ).
Peptide release in the brain
In the past ten years, studies of peptide actions in the brain have altered our understanding of neuronal communication. The conventional concept of synaptic transmission is that electrical information travels from the dendrites of a neuron to its soma, and thence to the axon terminals. However, dendrites also relay information from the soma to their own extremities and can also release neuroactive substances. Some substances, including nitric oxide, cannabinoids, neurotransmitters and peptides, act as retrograde signals, modulating the activity of afferent nerve terminals as well as autoregulating the cell of origin [40] . However, peptides persist long enough to diffuse to far distant sites.
The mechanisms of peptide release differ from those of classical neurotransmitters. In general, an increase in electrical activity results in increased secretion, and this is true of neurotransmitters released at synapses from small synaptic vesicles. Voltage-gated Ca 2+ entry is the major trigger for releasing synaptic vesicles that are docked to the synaptic membrane close to clusters of calcium channels. However, peptides are packaged in LDCVs (large dense-core vesicles) that are not conspicuously concentrated at synapses, and can be released from all parts of a neuron, including the soma and dendrites [1] . Dendrites contain approx. 85% of the volume of a neuron, and if, as in magnocellular neurons, they are densely filled with LDCVs, they constitute the major pool of releasable peptide [1] . From these compartments, the release of LDCVs can be regulated by factors that do not affect neurotransmitter release, in particular, by factors that mobilize intracellular Ca 2+ stores [1] . Such stores are extensive in somata and dendrites but often absent from nerve terminals.
Dendritic release of oxytocin
Dendrites can release very large amounts of peptide. The vasopressin-containing dendrites in the rat SON have been estimated to contain 1.9 × 10 8 LDCVs, each of which contains about 85 000 molecules of peptide [41] . So much peptide is released here that it can be measured readily by microdialysis. The extracellular oxytocin concentration in the SON is 100-1000-fold higher than in plasma, and this release has been implicated notably in retrograde modulation of afferent inputs to the SON [42] .
Exocytosis from the oxytocin nerve terminals is linked to electrical activity, although this link is highly nonlinear (high frequencies of spike discharge result in a dramatic facilitation of secretion). However, release from dendrites can occur wholly independently of spike activity [43] . Stimulation of the neural stalk triggers antidromic action potentials in magnocellular neurons, but does not normally release oxytocin within the SON [43] ; in vitro, only strong stimulation (100 Hz) of afferents or stimulation with long depolarizing pulses (10 ms pulses) produces significant dendritic release [42, 44] . However, some peptides [45] can trigger dendritic release without any direct increase in spike activity and without any oxytocin release into plasma. One peptide that can do so is the potent anorectic factor α-MSH (α-melanocytestimulating hormone); α-MSH is produced by POMC neurons in the arcuate nucleus and acts on MC4 (melanocortin 4) receptors to mobilize intracellular Ca 2+ stores in SON oxytocin neurons [46] . The behavioural actions of α-MSH are strikingly similar to those of oxytocin, i.e. inhibition of food intake and stimulation of male sexual behaviour, and indeed it is possible that oxytocin is a mediator of α-MSH actions [11] .
A key element that controls dendritic release is the increase in [ [43, 48] . This peptide-induced change in the function of a neuronal compartment produces a reconfiguration of the local neural network, opening new routes for communication between neurons. Importantly, priming is not a short-term phenomenon; it lasts for at least 90 min, suggesting a framework for understanding long-lasting behavioural effects of peptides.
In conclusion, until recently it was thought that the magnocellular oxytocin neurons of the hypothalamus were exclusively involved in the peripheral functions of oxytocin, particularly in lactation and during parturition. Now we know that these neurons can release very large amounts of oxytocin into the brain from their dendrites and that this central release can be regulated independently of release into the peripheral circulation. We know also that oxytocin can induce long-lasting functional changes at target neurons, suggesting an explanation of long-lasting behavioural consequences. One of the behavioural effects of oxytocin is to inhibit food intake, and as one of the most prominent sites of oxytocin receptor expression, the VMH, is a major satiety centre, it seems possible that oxytocin released from magnocellular sites acts here. Testing this hypothesis requires an integrated approach combining the use of in vivo microdialysis, to measure oxytocin released from the SON, and in vivo electrophysiology to record the mean electrical activity and membrane properties of VMH neurons.
